Integrated Investment Consultants LLC Increases Position in Core Laboratories Inc. (NYSE:CLB)

Integrated Investment Consultants LLC increased its stake in shares of Core Laboratories Inc. (NYSE:CLB) by 19.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 16,290 shares of the oil and gas company’s stock after buying an additional 2,709 shares during the quarter. Integrated Investment Consultants LLC’s holdings in Core Laboratories were worth $302,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in shares of Core Laboratories by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 5,392,034 shares of the oil and gas company’s stock valued at $92,096,000 after purchasing an additional 27,701 shares during the last quarter. Disciplined Growth Investors Inc. MN lifted its holdings in shares of Core Laboratories by 446.8% during the second quarter. Disciplined Growth Investors Inc. MN now owns 4,460,720 shares of the oil and gas company’s stock worth $90,508,000 after purchasing an additional 3,644,963 shares during the period. PEAK6 Investments LLC grew its position in Core Laboratories by 106.5% in the 1st quarter. PEAK6 Investments LLC now owns 61,005 shares of the oil and gas company’s stock valued at $1,042,000 after buying an additional 31,459 shares during the last quarter. Envestnet Asset Management Inc. increased its stake in Core Laboratories by 12.5% in the 2nd quarter. Envestnet Asset Management Inc. now owns 306,287 shares of the oil and gas company’s stock valued at $6,215,000 after buying an additional 34,149 shares during the period. Finally, Earnest Partners LLC raised its position in Core Laboratories by 6.3% during the 2nd quarter. Earnest Partners LLC now owns 3,286,438 shares of the oil and gas company’s stock worth $66,682,000 after buying an additional 195,756 shares during the last quarter. Institutional investors and hedge funds own 97.81% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on CLB. StockNews.com raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Stifel Nicolaus lifted their price objective on Core Laboratories from $18.00 to $22.00 and gave the company a “hold” rating in a report on Friday, July 26th. Finally, Citigroup dropped their target price on Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a research report on Thursday, October 31st. Two equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $17.00.

Core Laboratories Stock Performance

Shares of CLB opened at $21.27 on Friday. The company has a market capitalization of $998.63 million, a PE ratio of 32.72, a P/E/G ratio of 1.38 and a beta of 2.35. Core Laboratories Inc. has a 52-week low of $13.82 and a 52-week high of $25.13. The company has a 50-day simple moving average of $19.27 and a 200-day simple moving average of $19.42. The company has a quick ratio of 1.79, a current ratio of 2.48 and a debt-to-equity ratio of 0.55.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.04. The company had revenue of $134.40 million during the quarter, compared to the consensus estimate of $134.16 million. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. The company’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same period last year, the firm earned $0.22 EPS. Equities research analysts predict that Core Laboratories Inc. will post 0.77 earnings per share for the current fiscal year.

Core Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 25th. Shareholders of record on Monday, November 4th will be issued a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.19%. The ex-dividend date of this dividend is Monday, November 4th. Core Laboratories’s dividend payout ratio (DPR) is 6.15%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.